Boosting the Efficacy of A Key Cancer Treatment

News   Feb 21, 2017 | Original story from Sbarro Health Research Organization

 
Boosting the Efficacy of A Key Cancer Treatment

MicroRNA-125a-5p is a downstream effector of sorafenib in its antiproliferative activity toward human hepatocellular carcinoma cells. Credit: Sbarro Health Research Organization

 
 
FURTHER INFORMATION
 
 
 
 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Genomics Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE